Kubota Pharmaceutical Holdings Co (TSE:4596) Cyclically Adjusted PS Ratio: (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4596 Kubota Pharmaceutical Holdings Co Ltd TSE:4596
37 GF Score
Price 円68.00
GF Value 円21.07
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Kubota Pharmaceutical Holdings Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Kubota Pharmaceutical Holdings Co  (TSE:4596) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Kubota Pharmaceutical Holdings Co Cyclically Adjusted PS Ratio Related Terms


Kubota Pharmaceutical Holdings Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Kubota Pharmaceutical Holdings Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kubota Pharmaceutical Holdings Co Cyclically Adjusted PS Ratio Chart

Kubota Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kubota Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:4596 vs VRTX, REGN, RVMD: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Kubota Pharmaceutical Holdings Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kubota Pharmaceutical Holdings Co Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kubota Pharmaceutical Holdings Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kubota Pharmaceutical Holdings Co's Cyclically Adjusted PS Ratio falls into.


TSE:4596
37GF Score
Kubota Pharmaceutical Holdings Co Ltd TSE:4596
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kubota Pharmaceutical Holdings Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Kubota Pharmaceutical Holdings Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Kubota Pharmaceutical Holdings Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/113.6000*113.6000
=0.000

Current CPI (Jun. 2026) = 113.6000.

Kubota Pharmaceutical Holdings Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 0.000 98.100 0.000
201609 1.893 98.000 2.194
201612 0.756 98.400 0.873
201703 0.000 98.100 0.000
201706 0.000 98.500 0.000
201709 0.000 98.800 0.000
201712 0.000 99.400 0.000
201803 0.000 99.200 0.000
201806 0.000 99.200 0.000
201809 0.000 99.900 0.000
201812 0.000 99.700 0.000
201903 0.000 99.700 0.000
201906 0.000 99.800 0.000
201909 0.000 100.100 0.000
201912 0.000 100.500 0.000
202003 0.000 100.300 0.000
202006 0.893 99.900 1.015
202009 0.000 99.900 0.000
202012 0.000 99.300 0.000
202103 0.000 99.900 0.000
202106 0.000 99.500 0.000
202109 0.000 100.100 0.000
202112 0.000 100.100 0.000
202203 0.000 101.100 0.000
202206 0.000 101.800 0.000
202209 0.056 103.100 0.062
202212 0.100 104.100 0.109
202303 0.094 104.400 0.102
202306 0.217 105.200 0.234
202309 0.239 106.200 0.256
202312 0.166 106.800 0.177
202403 0.090 107.200 0.095
202406 0.084 108.200 0.088
202412 0.000 110.700 0.000
202503 0.126 111.100 0.129
202506 0.095 111.700 0.097
202509 0.089 112.000 0.090
202512 0.049 113.000 0.049
202603 0.039 112.700 0.039
202606 0.000 113.600 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?

Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued. The current stock price of 円68.00 is trading 222.7% above its estimated GF Value™ of 円21.07. GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.

Key valuation signals for TSE:4596:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: 円21.07 vs. price of 円68.00 (222.7% above fair value)
  • GF Score™: 37/100 with 2 warning signs

No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kubota Pharmaceutical Holdings Co Business Description

Address 1-15-37 Minami-Aoyama, Minato-ku, Tokyo, JPN, 107-0062
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
37GF Score

Get the complete analysis for TSE:4596

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円68.00
Price
円21.07
GF Value